SuperworthBriaCell Therapeutics shares outstanding BCTX
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Apr 30, 2026
- 7.3M
- On a year earlier
- +1843.5%
- more shares
BriaCell Therapeutics had 7.3M diluted shares outstanding on average in Q3 FY26, the quarter to Apr 30, 2026.
That is 1843.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 119.1K | +12% |
| FY2023 | 106.1K | +3% |
| FY2022 | 103.5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 7.3M | +1843% | |
| Q2 FY26 | 2.8M | +938% | |
| Q1 FY26 | 1.9M | +961% | |
| Q3 FY25 | 373.1K | +250% | |
| Q2 FY25 | 270K | +153% | |
| Q1 FY25 | 177.6K | +60% | |
| Q4 FY24 | 119.1K | +12% | |
| Q3 FY24 | 106.5K | +3% | |
| Q2 FY24 | 106.5K | +3% | |
| Q1 FY24 | 111.2K | +7% | |
| Q4 FY23 | 106.1K | +3% | |
| Q3 FY23 | 103.5K | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on BriaCell Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.